Patents by Inventor Ciaran Scallan

Ciaran Scallan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250082784
    Abstract: Provided herein are compositions and methods for generating an immunogenic response in humans. Further provided are methods for designing such compositions, e.g., for vaccines.
    Type: Application
    Filed: November 22, 2024
    Publication date: March 13, 2025
    Inventors: George Trager, Sean Tucker, Leesun Kim, Ciaran Scallan
  • Patent number: 12186407
    Abstract: Provided herein are compositions and methods for generating an immunogenic response in humans. Further provided are methods for designing such compositions, e.g., for vaccines.
    Type: Grant
    Filed: August 2, 2022
    Date of Patent: January 7, 2025
    Assignee: Vaxart, Inc.
    Inventors: George Trager, Sean Tucker, Leesun Kim, Ciaran Scallan
  • Publication number: 20220378944
    Abstract: Provided herein are compositions and methods for generating an immunogenic response in humans. Further provided are methods for designing such compositions, e.g., for vaccines.
    Type: Application
    Filed: August 2, 2022
    Publication date: December 1, 2022
    Inventors: George Trager, Sean Tucker, Leesun Kim, Ciaran Scallan
  • Patent number: 11433146
    Abstract: Provided herein are compositions and methods for generating an immunogenic response in humans. Further provided are methods for designing such compositions, e.g., for vaccines.
    Type: Grant
    Filed: June 8, 2016
    Date of Patent: September 6, 2022
    Assignee: Vaxart, Inc.
    Inventors: George Trager, Sean Tucker, Leesun Kim, Ciaran Scallan
  • Publication number: 20180161458
    Abstract: Provided herein are compositions and methods for generating an immunogenic response in humans. Further provided are methods for designing such compositions, e.g., for vaccines.
    Type: Application
    Filed: June 8, 2016
    Publication date: June 14, 2018
    Applicant: Vaxart, Inc.
    Inventors: George Trager, Sean Tucker, Leesun Kim, Ciaran Scallan
  • Publication number: 20170298389
    Abstract: Provided herein are improved vaccines for HSV-2.
    Type: Application
    Filed: October 9, 2015
    Publication date: October 19, 2017
    Applicant: Vaxart, Inc.
    Inventors: Ciaran Scallan, Wendy Peters
  • Publication number: 20120244185
    Abstract: The invention provides chimeric viral expression vectors and method of use for providing an immune response against H1N1 influenza. The compositions of the invention can be used as vaccines for H1N1 strains. Advantages include rapid development and availability once a strain is isolated, and effective oral or mucosal administration.
    Type: Application
    Filed: September 15, 2010
    Publication date: September 27, 2012
    Applicant: Vaxart ,Inc.
    Inventors: Sean N. Tucker, Ciaran Scallan